María‐Teresa Cedena

Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

Joaquín Martínez‐López, Juan José Lahuerta, François Pépin et al. · Blood · 2014 · 424 citations · Full text

Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials

Juan José Lahuerta, Bruno Paiva, María‐Belén Vídriales et al. · Journal of Clinical Oncology · 2017 · 305 citations · Full text

Hematological Malignancy, Prognostic Evaluation, Mrd Negativity +13

Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma

Bruno Paiva, Noemí Puig, María‐Teresa Cedena et al. · Journal of Clinical Oncology · 2019 · 261 citations · Full text

Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project

Andy C. Rawstron, Karl‐Anton Kreuzer, Asha Soosapilla et al. · Cytometry Part B Clinical Cytometry · 2017 · 192 citations · Full text

Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma

Cristina Pérez, Cirino Botta, Aintzane Zabaleta et al. · Blood · 2020 · 151 citations · Full text